收藏切换
Expert consensus on combined screening for common cancers (2025 edition)
收藏切换
PDF
Kexin Chen1, Wanqing Chen2, Yubei Huang1, Zhangyan Lyu1, Fangfang Song1, Changfa Xia2, Yongjie Xu2, Lei Yang3, Chao Sheng1, Yacong Zhang1, Peng Wang1, Yunmeng Zhang1, Yuting Ji1, Jingjing Li1, Wenxuan Li1, Jie Wu1, Qianyun Jin1, Fengju Song1, Expert Group for the Expert Consensus on Combined Screening for Common Cancers, Working Group for the Expert Consensus on Combined Screening for Common Cancers
Chinese Journal of Clinical Oncology | 2025, 52(14) : 703 - 726
Less
收藏切换
Chinese Journal of Clinical Oncology | 2025, 52(14): 703-726
Guidelines and Consensus
Expert consensus on combined screening for common cancers (2025 edition)
Full
Kexin Chen1, Wanqing Chen2, Yubei Huang1, Zhangyan Lyu1, Fangfang Song1, Changfa Xia2, Yongjie Xu2, Lei Yang3, Chao Sheng1, Yacong Zhang1, Peng Wang1, Yunmeng Zhang1, Yuting Ji1, Jingjing Li1, Wenxuan Li1, Jie Wu1, Qianyun Jin1, Fengju Song1, Expert Group for the Expert Consensus on Combined Screening for Common Cancers, Working Group for the Expert Consensus on Combined Screening for Common Cancers
Affiliations
  • 1Department of Epidemiology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin 300060, China
  • 2Office of Early Diagnosis and Early Treatment of Cancer, National Cancer Center/National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
  • 3Peking University Cancer Hospital (Inner Mongolia Campus)/Affiliated Cancer Hospital of Inner Mongolia Medical University, Inner Mongolia Cancer Center, Inner Mongolia 010020, China
Published: 2025-07-30 doi: 10.12354/j.issn.1000-8179.2025.20250757
Outline
收藏切换

Malignant tumors (commonly referred to as cancers) represent a major global public health challenge and contribute substantially to the global disease burden. Early screening plays a crucial role in improving detection rates, enabling timely intervention, and enhancing patient survival. However, current cancer screening guidelines primarily focus on site-specific screening, which may not fully address the need for comprehensive early detection. A scientifically rational, multi-cancer screening approach offers several advantages: it optimizes the use of biological samples, reduces the time burden for participants, enhances the efficiency and comprehensiveness of screening, and minimizes overall expenses. Moreover, this approach facilitates rational allocation of healthcare resources, ultimately helping to reduce the societal burden of cancer. To address gap, the Cancer Epidemiology Committee of the China Anti-Cancer Association has developed the Expert Consensus on Combined Screening for Common Cancers. This consensus integrates multidisciplinary expertise and synthesizes the latest domestic and international researches on cancer screening, early detection, and treatment of prevalent malignancies. Drawing upon China’s unique demographic and healthcare context and practical screening experiences, the consensus provides evidence-based recommendations on target populations, screening technologies, and procedural workflows for multi-cancer screening. These guidelines align with the principles and methodologies established by the World Health Organization (WHO), aiming to enhance the effectiveness of combined cancer screening in China, improve early detection rates, and provide a scientific foundation for national cancer prevention and control strategies.

malignant tumor  /  combined screening  /  early detection and treatment  /  consensus
Kexin Chen, Wanqing Chen, Yubei Huang, Zhangyan Lyu, Fangfang Song, Changfa Xia, Yongjie Xu, Lei Yang, Chao Sheng, Yacong Zhang, Peng Wang, Yunmeng Zhang, Yuting Ji, Jingjing Li, Wenxuan Li, Jie Wu, Qianyun Jin, Fengju Song, Expert Group for the Expert Consensus on Combined Screening for Common Cancers, Working Group for the Expert Consensus on Combined Screening for Common Cancers. Expert consensus on combined screening for common cancers (2025 edition)[J]. Chinese Journal of Clinical Oncology, 2025 , 52 (14) : 703 -726 . DOI: 10.12354/j.issn.1000-8179.2025.20250757
Year 2025 volume 52 Issue 14
PDF
176
80
Cite this Article
BibTeX
Article Info
doi: 10.12354/j.issn.1000-8179.2025.20250757
  • Receive Date:2025-06-06
  • Online Date:2026-04-09
  • Published:2025-07-30
Article Data
Affiliations
History
  • Received:2025-06-06
  • Revised:2025-06-30
Affiliations
    1Department of Epidemiology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin 300060, China
    2Office of Early Diagnosis and Early Treatment of Cancer, National Cancer Center/National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
    3Peking University Cancer Hospital (Inner Mongolia Campus)/Affiliated Cancer Hospital of Inner Mongolia Medical University, Inner Mongolia Cancer Center, Inner Mongolia 010020, China

Corresponding:

Kexin Chen; E-mail:
; Wanqing Chen; E-mail:
References
Share
https://castjournals.cast.org.cn/joweb/zgzllc/EN/10.12354/j.issn.1000-8179.2025.20250757
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT